These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9004339)

  • 21. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.
    Whale R; Quested DJ; Laver D; Harrison PJ; Cowen PJ
    Psychopharmacology (Berl); 2000 May; 150(1):120-2. PubMed ID: 10867985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute hormonal changes after IV citalopram and treatment response in OCD.
    Corregiari FM; Gattaz WF; Bernik M
    Psychopharmacology (Berl); 2007 Sep; 193(4):487-94. PubMed ID: 17492272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gender-related differences in functional assessment of serotonergic system in healthy young subjects].
    Silva H; Nieto R; Montes C; Paredes A; Rentería P; Ramírez A; Jérez S
    Actas Esp Psiquiatr; 2008; 36(4):218-22. PubMed ID: 18615275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recovery from major depression is not associated with normalization of serotonergic function.
    Flory JD; Mann JJ; Manuck SB; Muldoon MF
    Biol Psychiatry; 1998 Mar; 43(5):320-6. PubMed ID: 9513746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central 5-HT receptor hypersensitivity in migraine without aura.
    Cassidy EM; Tomkins E; Dinan T; Hardiman O; O'Keane V
    Cephalalgia; 2003 Feb; 23(1):29-34. PubMed ID: 12534577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal neuroendocrine responsivity to clomipramine in depression.
    Golden RN; Ruegg R; Brown TM; Haggerty J; Garbutt JC; Pedersen CA; Evans DL
    Psychopharmacol Bull; 1990; 26(3):317-20. PubMed ID: 2125736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infusion of a lipid emulsion in healthy men decreases the serotonergic response.
    Sondermeijer BM; Klein Twennaar CF; Kastelein JJ; Franssen EJ; Hutten BA; Dallinga-Thie GM; Stroes ES; Fliers E; Twickler MT; Serlie MJ
    Neuroendocrinology; 2012; 95(4):325-31. PubMed ID: 22327404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder.
    Mathew SJ; Coplan JD; Perko KA; Goetz RR; de la Neuz M; Hollander E; Liebowitz MR; Fallon BA
    Depress Anxiety; 2001; 14(4):199-208. PubMed ID: 11754126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D,L-fenfluramine challenge test: experience in nonpatient sample.
    Muldoon MF; Manuck SB; Jansma CL; Moore AL; Perel J; Mann JJ
    Biol Psychiatry; 1996 May; 39(9):761-8. PubMed ID: 8731516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients.
    Golden RN; Hsiao JK; Lane E; Ekstrom D; Rogers S; Hicks R; Potter WZ
    Psychiatry Res; 1990 Jan; 31(1):39-47. PubMed ID: 2156276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal study of serotonergic function in depression.
    Golden RN; Heine AD; Ekstrom RD; Bebchuk JM; Leatherman ME; Garbutt JC
    Neuropsychopharmacology; 2002 May; 26(5):653-9. PubMed ID: 11927190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in central serotonergic function as a correlate of duration of illness in paranoid schizophrenia.
    Angelopoulos EK; Markianos M; Daskalopoulou EG; Hatzimanolis J; Tzemos J
    Psychiatry Res; 2002 May; 110(1):9-17. PubMed ID: 12007589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of age and gender on CNS serotonergic responsivity in normal adults.
    McBride PA; Tierney H; DeMeo M; Chen JS; Mann JJ
    Biol Psychiatry; 1990 May; 27(10):1143-55. PubMed ID: 2340323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects.
    Ruegg RG; Gilmore J; Ekstrom RD; Corrigan M; Knight B; Tancer M; Leatherman ME; Carson SW; Golden RN
    Biol Psychiatry; 1997 Dec; 42(12):1123-9. PubMed ID: 9426882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cigarette smoking decreases the prolactin response to serotonergic stimulation in subgroups of alcoholics and controls.
    Anthenelli RM; Maxwell RA
    Alcohol Clin Exp Res; 2000 Jul; 24(7):987-95. PubMed ID: 10924001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study.
    McBride PA; Anderson GM; Hertzig ME; Sweeney JA; Kream J; Cohen DJ; Mann JJ
    Arch Gen Psychiatry; 1989 Mar; 46(3):213-21. PubMed ID: 2919950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J; Insel TR; Zohar-Kadouch RC; Hill JL; Murphy DL
    Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.